Loading organizations...
Clinical-stage pharmaceutical company developing novel therapies for diseas
Petra Pharma has raised $48.0M across 1 funding round.
Petra Pharma has raised $48.0M in total across 1 funding round.
Petra Pharma has raised $48.0M in total across 1 funding round.
Petra Pharma's investors include AbbVie Ventures, Alexandria Venture Investments, ARCH Venture Partners, Greg Plowman, Harris & Harris Group, Innovate NY Fund, Johnson & Johnson Innovation, Partnership Fund for New York City, Watson Fund, WuXi AppTec.
Petra Pharma has raised $48.0M across 1 funding round. Most recently, it raised $48.0M Series A in January 2016.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 6, 2016 | $48.0M Series A | AbbVie Ventures, Alexandria Venture Investments, ARCH Venture Partners, Greg Plowman, Harris & Harris Group, Innovate NY Fund, Johnson & Johnson Innovation, Partnership Fund for New York City, Watson Fund, WuXi AppTec |